|
1
|
Ochsenkühn R, von Schönfeldt V and Simoni
M: FSH receptor polymorphisms and ovarian function. Médecine de la
Reproduction. 11:265–270. 2009.
|
|
2
|
Artini P, Papini PG, Ruggiero M, Bartalini
G, de Leo V, Scaravelli G and Piomboni and Cela V: Genetic
screening in Italian infertile couples undergoing intrauterine
insemination and in vitro fertilization techniques: A multicentric
study. Gynecol Endocrinol. 27:453–457. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Poseidon Group (Patient-Oriented
Strategies Encompassing Individualized Oocyte Number). Alviggi C,
Andersen CY, Buehler K, Conforti A, de Placido G, Esteves SC,
Fischer R, Galliano D, Polyzos NP, et al: A new more detailed
stratification of low responders to ovarian stimulation: From a
poor ovarian response to a low prognosis concept. Fertil Steril.
105:1452–1453. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Humaidan P, Alviggi C, Fischer R and
Esteves SC: The novel POSEIDON stratification of ‘Low prognosis
patients in assisted reproductive technology’ and its proposed
marker of successful outcome. F1000Res. 5(2911)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Esteves SC, Roque M, Bedoschi GM, Conforti
A, Humaidan P and Alviggi C: Defining low prognosis patients
undergoing assisted reproductive technology: POSEIDON criteria -
the WHY. Front Endocrinol (Lausanne). 9(461)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Forman EJ, Hong KH, Ferry KM, Tao X,
Taylor D, Levy B, Treff NR and Scott RT Jr: In vitro fertilization
with single euploid blastocyst transfer: A randomized controlled
trial. Fertil Steril. 100:7–100.e1. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Altmäe S, Haller K, Peters M, Hovatta O,
Stavreus-Evers A, Karro H, Metspalu A and Salumets A: Allelic
estrogen receptor 1 (ESR1) gene variants predict the outcome of
ovarian stimulation in in vitro fertilization. Mol Hum Reprod.
13:521–526. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Alviggi C, Conforti A, Fabozzi F and de
Placido G: Ovarian stimulation for IVF/ICSI cycles: A
pharmacogenomic approach. Médecine de la Reproduction. 11:271–277.
2009.
|
|
9
|
Alviggi C, Clarizia R, Coppola G, de Rosa
P, de Biasio G, Pettersson K, de Placido G and Humaidan P: A common
LH polymorphism is associated with higher FSH consumption during
ovarian stimulation for IVF/ICSI cycles. Int J Gynecol Obstet. 107
(Suppl)(S105)2009.
|
|
10
|
Valkenburg O, Van Santbrink EJP, Themmen
APN, Uitterlinden AG, Fauser BCJM and Laven JSE: FSH receptor
polymorphism affects the outcome of ovulation induction in
normogonadotropic ovulatory infertility (WHOII). Mol Hum Reprod.
24(85)2009.
|
|
11
|
Fang HY: Genetic polymorphism analysis of
human follicle stimulating hormone receptor in Chinese women. Ther
Drug Monitoring. 33(507)2011.
|
|
12
|
Vilodre LC, Kohek MBF and Spritzer PM:
Screening of follicle-stimulating hormone receptor gene in women
with premature ovarian failure in Southern Brazil and associations
with phenotype. J Endocrinol Invest. 31:552–557. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Boudjenah R, Molina-Gomes D, Torre A,
Bergere M, Bailly M, Boitrelle F, Taieb S, Wainer R, Benahmed M, de
Mazancourt P, et al: Genetic polymorphisms influence the ovarian
response to rFSH stimulation in patients undergoing in vitro
fertilization programs with ICSI. PLoS One.
7(e38700)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mohiyiddeen L, Newman WG, McBurney H,
Mulugeta B, Roberts SA and Nardo LG: Follicle-stimulating hormone
receptor gene polymorphisms are not associated with ovarian reserve
markers. Fertil Steril. 97:677–681. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Loutradis D, Drakakis P, Vomvolaki E and
Antsaklis A: Different ovarian stimulation protocols for women with
diminished ovarian reserve. J Assist Reprod Genet. 24:597–611.
2007.PubMed/NCBI View Article : Google Scholar
|
